Involvement of Acetylcholine-α7nAChR in the Protective Effects of Arterial Baroreflex against Ischemic Stroke

CNS Neuroscience and Therapeutics

Volumn 18, Issue 11, 2012, Pages 918-926

  Liu, Ai Jun ^a   Zang, Pu ^a   Guo, Jin Min ^a   Wang, Wei ^a   Dong, Wen Zhe ^a   Guo, Wei ^a   Xiong, Zhi Gang ^b   Wang, Wei Zhong ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

7 Nicotinic acetylcholine receptor; Acetylcholine; Arterial baroreflex; Stroke

Indexed keywords

ANISODAMINE; BUNGAROTOXIN RECEPTOR; NEOSTIGMINE; VECURONIUM; VESICULAR ACETYLCHOLINE TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DENERVATION; IN VITRO STUDY; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRESSORECEPTOR REFLEX; RAT;

ANIMALS; BAROREFLEX; BRAIN ISCHEMIA; CELLS, CULTURED; MALE; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; MIDDLE CEREBRAL ARTERY; NEOSTIGMINE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; STROKE;

EID: 84868144702     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12011     Document Type: Article

References (38)

1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008;371:1612-1623.
2. Yu JG, Zhou RR, Cai GJ. From hypertension to stroke: Mechanisms and potential prevention strategies. CNS Neurosci Ther 2011;17:577-584.
3. Flynn RW, MacWalter RS, Doney AS. The cost of cerebral ischaemia. Neuropharmacology 2008;55:250-266.
4. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
5. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998;351:478-484.
6. Mortara A, La Rovere MT, Pinna GD, et al. Arterial baroreflex modulation of heart enhancing baroreflex function is within the rostral ventrolateral medulla rate in chronic heart failure: Clinical and hemodynamic correlates and prognostic implications. Circulation 1997;96:3450-3458.
7. Liu AJ, Ma XJ, Shen FM, Liu JG, Chen H, Su DF. Arterial baroreflex: A novel target for preventing stroke in rat hypertension. Stroke 2007;38:1916-1923.
8. Gerritsen J, TenVoorde BJ, Dekker JM, Kostense PJ, Bouter LM, Heethaar RM. Baroreflex sensitivity in the elderly: Influence of age, breathing and spectral methods. Clin Sci (Lond) 2000;99:371-381.
9. Eames PJ, Blake MJ, Dawson SL, Panerai RB, Potter JF. Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2002;72:467-472.
10. Eveson DJ, Robinson TG, Shah NS, Panerai RB, Paul SK, Potter JF. Abnormalities in cardiac baroreceptor sensitivity in acute ischaemic stroke patients are related to aortic stiffness. Clin Sci (Lond) 2005;108:441-447.
11. Sykora M, Diedler J, Rupp A, Turcani P, Rocco A, Steiner T. Impaired baroreflex sensitivity predicts outcome of acute intracerebral hemorrhage. Crit Care Med 2008;36:3074-3079.
12. Robinson TG, Dawson SL, Eames PJ, Panerai RB, Potter JF. Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke 2003;34:705-712.
13. Liu AJ, Ling G, Wu J, et al. Arterial baroreflex function is an important determinant on the acute cerebral ischemia in rats with middle cerebral artery occlusion. Life Sci 2008;83:388-393.
14. Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: The non-neuronal cholinergic system in humans. Br J Pharmacol 2008;154:1558-1571.
15. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003;421:384-388.
16. Guarini S, Altavilla D, Cainazzo MM, et al. Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003;107:1189-1194.
17. Shimohama S. Nicotinic receptor-mediated neuroprotection in neurodegene- rative disease models. Biol Pharm Bull 2009;32:332-336.
18. Tracey KJ. The inflammatory reflex. Nature 2002;420:853-859.
19. Wang P, Tian WW, Song J, Guan YF, Miao CY. Deficiency of NG2+ cells contributes to the susceptibility of stroke-prone spontaneously hypertensive rats. CNS Neurosci Ther 2011;17:327-332.
20. Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007;13:688-694.
21. Alirezaei M, Kemball CC, Flynn CT, Wood MR, Whitton JL, Kiosses WB. Short-term fasting induces profound neuronal autophagy. Autophagy 2010;6:702-710.
22. Zhang X, Li L, Chen S, et al. Rapamycin treatment augments motor neuron degeneration in SOD1 (G93A) mouse model of amyotrophic lateral sclerosis. Autophagy 2011;7:412-425.
23. Cai GJ, Miao CY, Xie HH, Lu LH, Su DF. Arterial baroreflex dysfunction promotes atherosclerosis in rats. Atherosclerosis 2005;183:41-47.
24. Shen FM, Guan YF, Xie HH, Su DF. Arterial baroreflex function determines the survival time in lipopolysaccharide-induced shock in rats. Shock 2004;21:556-560.
25. Shu H, Yi-Ming W, Xu LP, Miao CY, Su DF. Increased susceptibility of ventricular arrhythmia to aconitine in anesthetized rats is attributed to the inhibition of baroreflex. Clin Exp Pharmacol Physiol 2004;31:249-253.
26. Sykora M, Diedler J, Turcani P, Hacke W, Steiner T. Baroreflex: A new therapeutic target in human stroke? Stroke 2009;40:e678-e682.
27. Ormezzano O, Cracowski JL, Quesada JL, Pierre H, Mallion JM, Baguet JP. Evaluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: The EVABAR study. J Hypertens 2008;26:1373-1378.
28. Yu JG, Song SW, Shu H, et al. Baroreflex deficiency hampers angiogenesis after myocardial infarction via acetylcholine-α7-nicotinic ACh receptor in rats. Eur Heart J 2011; doi:10.1093/eurheartj/ehr299
29. Prado VF, Martins-Silva C, de Castro BM, et al. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 2006;51:601-612.
30. Guidine PA, Rezende GH, Queiroz CM, et al. Vesicular acetylcholine transporter knock-down mice are more susceptible to pilocarpine induced status epilepticus. Neurosci Lett 2008;436:201-204.
31. Clarke PB, Schwartz RD, Paul SM, Pert CB, Pert A. Nicotinic binding in rat brain: Autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]- alpha-bungarotoxin. J Neurosci 1985;5:1307-1315.
32. Lindstrom J, Anand R, Peng X, Gerzanich V, Wang F, Li Y. Neuronal nicotinic receptor subtypes. Ann N Y Acad Sci 1995;757:100-116.
33. Egleton RD, Brown KC, Dasgupta P. Nicotinic acetylcholine receptors in cancer: Multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 2008;29:151-158.
34. Parada E, Egea J, Romero A, del Barrio L, García AG, López MG. Poststress treatment with PNU282987 can rescue SH-SY5Y cells undergoing apoptosis via α7 nicotinic receptors linked to a Jak2/Akt/HO-1 signaling pathway. Free Radic Biol Med 2010;49:1815-1821.
35. Scremin OU, Sonnenschein RR, Rubinstein EH. Cholinergic cerebral vasodilatation in the rabbit: Absence of concomitant metabolic activation. J Cereb Blood Flow Metab 1982;2:241-247.
36. Akaike A, Takada-Takatori Y, Kume T, Izumi Y. Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: Role of alpha4 and alpha7 receptors in neuroprotection. J Mol Neurosci 2010;40:211-216.
37. Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med 2009;265:663-679.
38. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: The Edinburgh Artery Study. Circulation 2007;115:2119-2127.